Clinical Trial Update: Effect of Glucose-Insulin-Potassium on Hyperlactatemia in Patients Undergoing Valvular Heart Surgery [NA]

View source ↗

Summary

A completed clinical trial evaluating whether glucose-insulin-potassium can mitigate hyperlactatemia in patients undergoing valvular heart surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Valvular Heart Disease

Drugs mentioned

• Glucose-Insulin-Potassium (Glucose-Insulin-Potassium)

Snippet

Sponsor: Yonsei University | Conditions: Valvular Heart Disease | NA | Status: COMPLETED